Cargando...

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma

Even though classical Hodgkin lymphoma is highly curable, the outcome of patients with a refractory or relapsed disease has been disappointing. Multiple lines of therapy are available for patients after their first failure, and most respond to subsequent therapies. However, there is a sizable propor...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World J Oncol
Main Authors: Tarekegn, Kidist, Colon Ramos, Ana, Singh, Balraj, Sequeira Gross, Harry G., Gupta, Sachin
Formato: Artigo
Idioma:Inglês
Publicado: Elmer Press 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8297052/
https://ncbi.nlm.nih.gov/pubmed/34349851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1388
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!